Industrial purity specifications play a pivotal role in ensuring that 1,2-butylene oxide — a key intermediate with CAS number 106-88-7, molecular formula C4H8O, and a molecular weight of 72.11 g/mol — delivers consistent performance in polymer and surfactant manufacturing. For applications where this epoxide is further processed in downstream pharmaceutical synthesis, the integrity of both the chemical and its accompanying documentation is more than a regulatory requirement; it is the foundation of product safety and process reliability. Maintaining an assay of at least 99.5%, rigorously limiting water and impurity levels, and providing comprehensive Certificates of Analysis bring substantial value, not only in process efficiency but also in regulatory compliance and customer assurance.
The competitive landscape of fine chemical production demands that manufacturers balance cost efficiency against stringent quality targets. In polymer and surfactant sectors, where bulk raw materials often represent significant input costs, manufacturers cannot compromise on the purity thresholds that safeguard batch-to-batch reproducibility and optimal yields. When 1,2-butylene oxide is used for pharmaceutical intermediate synthesis, the stakes rise exponentially — impurities can not only erode yields or catalyst activity, but also introduce liabilities associated with regulatory non-compliance or patient safety risks. High-value sectors rely on trusted ISO-certified suppliers who deploy validated analytical methods to verify each batch. The product’s appearance, documentation, and compliance with international quality benchmarks offer both operational confidence and a strategic edge.
Defining the appropriate level of purity for 1,2-butylene oxide depends on end-use requirements and the downstream regulatory landscape. Industrial grades for polymer and surfactant manufacturing typically call for a minimum assay threshold of 99.5%, with specifications focused on cost-optimized production and robust supply logistics. These grades address the critical needs for consistent reaction outcomes, high throughput, and storage stability, but may tolerate trace levels of process-related impurities if performance impact is proven negligible. By contrast, pharmaceutical and so-called “ultra-pure” grades of 1,2-butylene oxide build upon these foundations with further controls. Here, the requirements expand to address the presence of genotoxic impurities, adherence to ICH Q3C guidance for residual solvents, and compliance with elemental impurity thresholds as stipulated by ICH Q3D. ISO 9001-certified suppliers, such as Technical Insights, ensure that both routine and exceptional quality requirements are captured in a harmonized quality management system. This framework supports traceability from incoming raw materials to outgoing bulk consignments, making regulatory audits more straightforward and cross-industry compliance easier to demonstrate. Further details about product availability and technical documentation are available on our dedicated product page for 1,2-butylene oxide.
Establishing and verifying a minimum assay of 99.5% in bulk batches of 1,2-butylene oxide is only feasible with a suite of validated analytical techniques. Gas chromatography (GC) using a capillary column with flame ionization detection (FID) is the gold standard for quantifying purity and detecting trace organic impurities, leveraging its sensitivity and resolution. High-performance liquid chromatography (HPLC) offers complementary selectivity, particularly for non-volatile contaminants or isomeric byproducts. Water content is most accurately determined using volumetric Karl Fischer titration, an essential step because even low water levels can catalyze unwanted hydrolysis or affect storage life. Residual organic impurities (ROI), including possible residual solvents as identified per ICH Q3C, are detected by GC as well. For elemental impurities such as lead, cadmium, arsenic, and mercury, inductively coupled plasma mass spectrometry (ICP-MS) enables detection at sub-ppm levels, ensuring alignment with ICH Q3D criteria. The complete Certificate of Analysis (COA) routinely includes chemical name, CAS number, molecular formula, molecular weight, batch-specific appearance, assay percentage, water content, residual organic and inorganic content, recommended storage conditions, and shelf life. For context, a typical industrial specification for 1,2-butylene oxide incorporates the following: the chemical name and CAS number for unequivocal identification; the empirical formula C4H8O and molecular weight 72.11 g/mol for procedural reference; clear documentation of physical appearance such as a clear, colorless liquid; an assay of not less than 99.5% by GC; water content not exceeding 0.05% determined via Karl Fischer; residue on ignition limited to 0.01%; shelf life established at 12 months when stored in sealed containers at 2-8°C; and all results verified by the stated methods. In addition, the COA will attest to compliance with USP, ICH, and internal specifications.
Maintaining tight control over water content and impurity levels in 1,2-butylene oxide directly influences downstream synthesis, particularly in high-value sectors such as pharmaceutical intermediates production. Water, even at low ppm levels, can initiate undesirable hydrolysis reactions that generate glycol byproducts, alter polymer chain propagation, or deactivate sensitive catalysts — ultimately leading to reduced yield and off-spec polymer or surfactant products. Isomeric or structurally related impurities can interfere with reaction selectivity or affect the rheological properties of end products. For surfactant synthesis, small amounts of high-boiling or UV-active impurities can disrupt product homogeneity and shelf stability. Robust, in-process quality controls are essential; regular batch sampling and real-time analytical feedback, including frequent use of GC-FID and Karl Fischer titration, help to ensure that contamination or process drift is detected and rectified before customer delivery.
For industrial buyers and pharmaceutical formulators alike, sourcing bulk 1,2-butylene oxide with guaranteed purity hinges on supplier transparency and robust documentation. Professional suppliers routinely offer packaging in both steel and high-density polyethylene drums, with secondary containment and tamper-evident seals to prevent external contamination. Alongside the physical product, customers receive a full certification package including a Certificate of Analysis for each lot, a Safety Data Sheet detailing transport and hazard information, and a Certificate of Origin where needed for international compliance. The supply chain is supported by quality management systems in accordance with ISO 9001, covering everything from vendor qualification to in-process analytical verification and post-shipment traceability. In-process testing maintains alignment with both internal quality standards and those enshrined in regulatory frameworks such as USP and ICH. This integrated approach minimizes supply chain risk and delivers confidence in every ton delivered.
In summary, purity is not simply a technical parameter but a strategic asset in the industrial and pharmaceutical supply chains for 1,2-butylene oxide. By maintaining rigorous purity specifications — such as a minimum 99.5% assay, ultra-low water and residual impurity levels, and robust documentation — manufacturers safeguard both process performance and end product quality. ISO-certified suppliers who combine validated analytical testing with transparent documentation processes enable customers to meet not only immediate production goals but also the evolving demands of regulatory oversight and product stewardship. In today’s global fine chemicals marketplace, expertly managed purity is a key differentiator — a guarantee of reliable performance and a foundation for future innovation.
Related Articles
